<DOC>
	<DOCNO>NCT02710669</DOCNO>
	<brief_summary>Propafenone currently use medicine treat atrial fibrillation mixture two compound , ( R ) -propafenone ( S ) -propafenone . In study , investigator randomize participant ( R ) -propafenone , ( S ) -propafenone , placebo .</brief_summary>
	<brief_title>New Formulations Propafenone Treat Atrial Fibrillation</brief_title>
	<detailed_description>Atrial fibrillation common cardiac arrhythmia need development effective medication . Propafenone medicine currently use treat atrial fibrillation mixture two compound , ( R ) -propafenone ( S ) -propafenone . The investigator discover purify ( R ) -propafenone may effective ( S ) -propafenone treatment atrial fibrillation , ( S ) -propafenone reduces efficacy ( R ) -propafenone administer mixture . This study compare ability ( R ) -propafenone , ( S ) -propafenone , placebo suppress induction atrial fibrillation participant undergo atrial fibrillation ablation procedure .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Propafenone</mesh_term>
	<criteria>Inclusion : 1 . History atrial fibrillation 2 . Greater equal 18 year age 3 . Scheduled undergo atrial fibrillation ablation procedure 4 . Able provide write informed consent Exclusion : 1 . Longstanding persistent atrial fibrillation time ablation ( great 1 year continuous atrial fibrillation episode ) 2 . Is atrial fibrillation atrial flutter morning ablation procedure 3 . The presence follow patient without permanent pacemaker implantable cardiac defibrillator 1. sick sinus syndrome indicate inability previously tolerate antiarrhythmic drug due bradycardia 2. sinus bradycardia heart rate le 50 beat per minute time study drug administration 3. right bundle branch block , leave bundle branch block , bifascicular block 4 . PRinterval &gt; 280ms , history 2nd 3rd degree atrioventricular block 4 . Concomitant use CYP3A4 CYP2D6 inhibitor 5 . Previous surgical catheter ablation atrial fibrillation CoxMaze procedure 6 . Amiodarone use within 3 month prior enrollment 7 . Antiarrhythmic drug ( amiodarone ) within 5 halflives prior atrial fibrillation ablation 8 . Expected life span &lt; 1 year 9 . Creatinine clearance &lt; 30 mL/min 10 . Reversible cause atrial fibrillation ( ie . thyrotoxicosis ) 11 . Unrevascularized coronary artery disease 12 . Canadian class IV angina 13 . Left ventricular ejection fraction &lt; 40 % 14 . New York Heart Association Class III IV symptoms 15 . Previous heart transplantation 16 . Planned heart transplantation ventricular assist device 17 . Cardiac/thoracic surgery &lt; 6 month prior enrollment 18 . Severe asthma chronic obstructive pulmonary disease 19 . Breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>ablation</keyword>
</DOC>